Skip to main content
PMC home page
Gut logoLink to Gut
. 1994 Oct;35(10):1493–1496. doi: 10.1136/gut.35.10.1493

Mesalazine induced interstitial nephritis.

P J Thuluvath 1, M Ninkovic 1, J Calam 1, M Anderson 1
PMCID: PMC1375033  PMID: 7959212

Abstract

5-Aminosalicylic acid (5-ASA) has structural similarities to both phenacetin and aspirin, which are known to cause 'analgesic nephropathy'. Because of the increasing use of 5-ASA, this paper draws attention to two cases of severe interstitial nephritis resulting from 5-ASA and emphasises the importance of monitoring renal functions of patients with inflammatory bowel diseases who are receiving 5-ASA preparations.

Full text

PDF
1493

Images in this article

1494p1494-a
on p.1494

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abraham P. A., Stillman M. T. Salsalate exacerbation of chronic renal insufficiency. Relation to inhibition of prostaglandin synthesis. Arch Intern Med. 1987 Sep;147(9):1674–1676. [PubMed] [Google Scholar]
  2. Barbour V. M., Williams P. F. Nephrotic syndrome associated with sulphasalazine. BMJ. 1990 Oct 6;301(6755):818–818. doi: 10.1136/bmj.301.6755.818-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bondesen S., Nielsen O. H., Jacobsen O., Rasmussen S. N., Hansen S. H., Halskov S., Binder V., Hvidberg E. F. 5-Aminosalicylic acid enemas in patients with active ulcerative colitis. Influence of acidity on the kinetic pattern. Scand J Gastroenterol. 1984 Jul;19(5):677–682. [PubMed] [Google Scholar]
  4. Brezin J. H., Katz S. M., Schwartz A. B., Chinitz J. L. Reversible renal failure and nephrotic syndrome associated with nonsteroidal anti-inflammatory drugs. N Engl J Med. 1979 Dec 6;301(23):1271–1273. doi: 10.1056/NEJM197912063012306. [DOI] [PubMed] [Google Scholar]
  5. Briggs D., Calder I., Woods R., Tange J. The influence of metabolic variation on analgesic nephrotoxicity. Experiments with the Gunn rat. Pathology. 1982 Oct;14(4):349–353. doi: 10.3109/00313028209092108. [DOI] [PubMed] [Google Scholar]
  6. Calder I. C., Funder C. C., Green C. R., Ham K. N., Tange J. D. Nephrotoxic lesions from 5-aminosalicylic Acid. Br Med J. 1972 Jan 15;1(5793):152–154. doi: 10.1136/bmj.1.5793.152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Campieri M., Lanfranchi G. A., Boschi S., Brignola C., Bazzocchi G., Gionchetti P., Minguzzi M. R., Belluzzi A., Labò G. Topical administration of 5-aminosalicylic acid enemas in patients with ulcerative colitis. Studies on rectal absorption and excretion. Gut. 1985 Apr;26(4):400–405. doi: 10.1136/gut.26.4.400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Casadevall G., Moreno J. J., Franch M. A., Queralt J. N-acetyl-beta-D-glucosaminidase (NAG) and alanine aminopeptidase (AAP) excretion after acute administration of acetaminophen, salsalate and aspirin in rats. Res Commun Chem Pathol Pharmacol. 1993 Jul;81(1):77–89. [PubMed] [Google Scholar]
  9. Chester A. C., Diamond L. H., Schreiner G. E. Hypersensitivity to salicylazosulfapyridine: renal and hepatic toxic reactions. Arch Intern Med. 1978 Jul;138(7):1138–1139. doi: 10.1001/archinte.138.7.1138. [DOI] [PubMed] [Google Scholar]
  10. Christensen L. A., Fallingborg J., Abildgaard K., Jacobsen B. A., Sanchez G., Hansen S. H., Bondesen S., Hvidberg E. F., Rasmussen S. N. Topical and systemic availability of 5-aminosalicylate: comparisons of three controlled release preparations in man. Aliment Pharmacol Ther. 1990 Oct;4(5):523–533. doi: 10.1111/j.1365-2036.1990.tb00499.x. [DOI] [PubMed] [Google Scholar]
  11. Clive D. M., Stoff J. S. Renal syndromes associated with nonsteroidal antiinflammatory drugs. N Engl J Med. 1984 Mar 1;310(9):563–572. doi: 10.1056/NEJM198403013100905. [DOI] [PubMed] [Google Scholar]
  12. Dubach U. C., Rosner B., Pfister E. Epidemiologic study of abuse of analgesics containing phenacetin. Renal morbidity and mortality (1968-1979). N Engl J Med. 1983 Feb 17;308(7):357–362. doi: 10.1056/NEJM198302173080703. [DOI] [PubMed] [Google Scholar]
  13. Duggin G. G. Mechanisms in the development of analgesic nephropathy. Kidney Int. 1980 Nov;18(5):553–561. doi: 10.1038/ki.1980.173. [DOI] [PubMed] [Google Scholar]
  14. Finkelstein A., Fraley D. S., Stachura I., Feldman H. A., Gandy D. R., Bourke E. Fenoprofen nephropathy: lipoid nephrosis and interstitial nephritis. A possible T-lymphocyte disorder. Am J Med. 1982 Jan;72(1):81–87. doi: 10.1016/0002-9343(82)90591-5. [DOI] [PubMed] [Google Scholar]
  15. Haagen Nielsen O., Bondesen S. Kinetics of 5-aminosalicylic acid after jejunal instillation in man. Br J Clin Pharmacol. 1983 Dec;16(6):738–740. doi: 10.1111/j.1365-2125.1983.tb02254.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Henning H. V., Meinhold J., Eisenhauer T., Scheler F., Gröne H. J. Chronische interstitielle Nephritis nach Behandlung mit 5-Aminosalicylsäure. Dtsch Med Wochenschr. 1989 Jul 7;114(27):1091–1091. [PubMed] [Google Scholar]
  17. Ireland A., Priddle J. D., Jewell D. P. Acetylation of 5-aminosalicylic acid by isolated human colonic epithelial cells. Clin Sci (Lond) 1990 Jan;78(1):105–111. doi: 10.1042/cs0780105. [DOI] [PubMed] [Google Scholar]
  18. Mehta R. P. Acute interstitial nephritis due to 5-aminosalicylic acid. CMAJ. 1990 Nov 15;143(10):1031–1032. [PMC free article] [PubMed] [Google Scholar]
  19. Myers B., Evans D. N., Rhodes J., Evans B. K., Hughes B. R., Lee M. G., Richens A., Richards D. Metabolism and urinary excretion of 5-amino salicylic acid in healthy volunteers when given intravenously or released for absorption at different sites in the gastrointestinal tract. Gut. 1987 Feb;28(2):196–200. doi: 10.1136/gut.28.2.196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Novis B. H., Korzets Z., Chen P., Bernheim J. Nephrotic syndrome after treatment with 5-aminosalicylic acid. Br Med J (Clin Res Ed) 1988 May 21;296(6634):1442–1442. doi: 10.1136/bmj.296.6634.1442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Patrono C., Pierucci A. Renal effects of nonsteroidal anti-inflammatory drugs in chronic glomerular disease. Am J Med. 1986 Aug 25;81(2B):71–83. doi: 10.1016/0002-9343(86)90909-5. [DOI] [PubMed] [Google Scholar]
  22. Pieniaszek H. J., Jr, Bates T. R. Capacity-limited gut wall metabolism of 5-aminosalicylic acid, a therapeutically active metabolite of sulfasalazine, in rats. J Pharm Sci. 1979 Oct;68(10):1323–1325. doi: 10.1002/jps.2600681036. [DOI] [PubMed] [Google Scholar]
  23. Rasmussen S. N., Bondesen S., Hvidberg E. F., Hansen S. H., Binder V., Halskov S., Flachs H. 5-aminosalicylic acid in a slow-release preparation: bioavailability, plasma level, and excretion in humans. Gastroenterology. 1982 Nov;83(5):1062–1070. [PubMed] [Google Scholar]
  24. Reimann I. W., Golbs E., Fischer C., Frölich J. C. Influence of intravenous acetylsalicylic acid and sodium salicylate on human renal function and lithium clearance. Eur J Clin Pharmacol. 1985;29(4):435–441. doi: 10.1007/BF00613458. [DOI] [PubMed] [Google Scholar]
  25. Rijk M. C., van Hogezand R. A., van Schaik A., van Tongeren J. H. Disposition of 5-aminosalicylic acid from 5-aminosalicylic acid-delivering drugs during accelerated intestinal transit in healthy volunteers. Scand J Gastroenterol. 1989 Dec;24(10):1179–1185. doi: 10.3109/00365528909090784. [DOI] [PubMed] [Google Scholar]
  26. Rijk M. C., van Schaik A., van Tongeren J. H. Disposition of 5-aminosalicylic acid by 5-aminosalicylic acid-delivering compounds. Scand J Gastroenterol. 1988 Jan;23(1):107–112. doi: 10.3109/00365528809093858. [DOI] [PubMed] [Google Scholar]
  27. Ruf-Ballauf W., Hofstädter F., Krentz K. Akute interstitielle Nephritis durch 5-Aminosalicylsäure? Internist (Berl) 1989 Apr;30(4):262–264. [PubMed] [Google Scholar]
  28. Staerk Laursen L., Stokholm M., Bukhave K., Rask-Madsen J., Lauritsen K. Disposition of 5-aminosalicylic acid by olsalazine and three mesalazine preparations in patients with ulcerative colitis: comparison of intraluminal colonic concentrations, serum values, and urinary excretion. Gut. 1990 Nov;31(11):1271–1276. doi: 10.1136/gut.31.11.1271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. von Mühlendahl K. E. Nephritis durch 5-Aminosalicylsäure. Dtsch Med Wochenschr. 1989 Feb 10;114(6):236–236. [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES